[HTML][HTML] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia
OG Ottmann, RA Larson, HM Kantarjian, PD Le Coutre… - Leukemia, 2013 - nature.com
The t (9; 22)(q34; q11) translocation, known as the Philadelphia chromosome (Ph), is
present in B15–30% of adult patients with acute lymphoblastic leuremia (ALL). 1 This …
present in B15–30% of adult patients with acute lymphoblastic leuremia (ALL). 1 This …
[引用][C] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia.
OG Ottmann, RA Larson, HM Kantarjian, PD le Coutre… - Leukemia, 2012 - europepmc.org
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive
acute lymphoblastic leukemia. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
acute lymphoblastic leukemia. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
[引用][C] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosomepositive acute lymphoblastic leukemia
OG Ottmann - Leukemia, 2013 - cir.nii.ac.jp
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia
chromosomepositive acute lymphoblastic leukemia | CiNii Research CiNii 国立情報学 …
chromosomepositive acute lymphoblastic leukemia | CiNii Research CiNii 国立情報学 …
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia
OG Ottmann, RA Larson, HM Kantarjian, PD le Coutre… - Leukemia, 2013 - go.gale.com
The t (9; 22)(q34; q11) translocation, known as the Philadelphia chromosome (Ph), is
present in~ 15-30% of adult patients with acute lymphoblastic leuremia (ALL).(1) This …
present in~ 15-30% of adult patients with acute lymphoblastic leuremia (ALL).(1) This …
[引用][C] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia
OG Ottmann, RA Larson, HM Kantarjian… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive
acute lymphoblastic leukemia Phase II study of nilotinib in patients with relapsed or refractory …
acute lymphoblastic leukemia Phase II study of nilotinib in patients with relapsed or refractory …
[引用][C] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome-Positive acute lymphoblastic leukemia
OG Ottmann, RA Larson, HM Kantarjian… - …, 2013 - scholars.northwestern.edu
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome -
Positive acute lymphoblastic leukemia — Northwestern Scholars Skip to main navigation Skip …
Positive acute lymphoblastic leukemia — Northwestern Scholars Skip to main navigation Skip …
[引用][C] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
OG Ottmann, RA Larson, HM Kantarjian… - Leukemia …, 2013 - search.ebscohost.com
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia
chromosome—positive acute lymphoblast Page 1 commitment by suppressing …
chromosome—positive acute lymphoblast Page 1 commitment by suppressing …
[引用][C] Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome-Positive acute lymphoblastic leukemia
OG Ottmann, RA Larson, HM Kantarjian… - …, 2013 - mdanderson.elsevierpure.com
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome -
Positive acute lymphoblastic leukemia — MD Anderson Cancer Center Skip to main …
Positive acute lymphoblastic leukemia — MD Anderson Cancer Center Skip to main …